Ons laatste nieuws
Netherlands Innovation Hub Plans 16,500 New Jobs by 2035
Enschede, Sunday, 15 March 2026.
Kennispark Twente has launched an ambitious decade-long strategy to transform into the technological heart of eastern Netherlands, targeting 700 companies and 16,500 jobs by 2035. The 230-hectare innovation campus currently hosts 480 companies and 12,000 students, generating nearly €1 billion annually. The strategy focuses on attracting knowledge-intensive startups, scale-ups, and established tech firms, particularly in semiconductor and medical technology sectors, while developing into a complete innovation ecosystem from research to market deployment.
Laatste nieuws in green
Dutch Homeowners Face Financial Squeeze as Government Cuts Green Heating Subsidies
Netherlands, Saturday, 14 March 2026.
Thousands of Dutch residents who invested in pellet heating systems are now struggling with unexpected costs after the government slashed subsidies they relied upon. Anja from Kempen, who spent €7,000 on a pellet boiler in 2021 based on promised support, exemplifies families caught between climate promises and budget realities. The policy reversal undermines the Netherlands’ green transition strategy and erodes public trust in renewable energy initiatives, leaving homeowners to bear the financial burden of political inconsistency in climate policy.
Laatste nieuws in community
Dutch Tech Hub Eindhoven Tackles Student Housing Crisis with 5,400 New Homes
Eindhoven, Saturday, 14 March 2026.
Eindhoven has committed to building 5,400 student homes by 2034 in partnership with major universities and housing organizations, representing one of the Netherlands’ largest student housing expansions. The initiative addresses a critical shortage that forced 500 students to drop out in September 2025 due to lack of accommodation. The collaboration involves TU/e, Fontys University, and housing corporation SSH across fifteen development sites. Funding comes partly from the €2.5 billion Beethoven program designed to retain tech companies like ASML in the region.
Laatste nieuws in data
Dutch Fintech Founders Miss Critical Warning Signs as Startups Transform into Banking Operations
Amsterdam, Saturday, 14 March 2026.
Netherlands fintech companies are struggling with a dangerous blind spot: failing to recognize when their platforms have evolved from simple startups into complex financial institutions requiring enterprise-level controls. As these platforms mature and handle larger transaction volumes, founders often underestimate the sophisticated operational infrastructure needed for treasury management, settlement coordination, and regulatory compliance. Warning signs include longer reconciliation processes, expanding operational teams, and increasing regulatory scrutiny. Companies that delay implementing proper control systems face operational friction that can threaten growth, while those investing early in enterprise-grade infrastructure scale more smoothly through this critical transition phase.
Laatste nieuws in semicon
ASML Cuts 1,700 Jobs Despite Record Profits to Fight Corporate Bloat
Veldhoven, Saturday, 14 March 2026.
Dutch semiconductor giant ASML eliminated 1,700 positions in January 2026 after earning €10 billion in profits, with Technical Director Marco Pieters declaring the company had become ‘sluggish’ and wasteful. The restructuring affects 4,500 managers who must reapply for positions as ASML streamlines its 16,000-person engineering division. Pieters admits the company lost efficiency through excessive meetings and bureaucratic processes during rapid growth, contradicting typical corporate logic of hiring during boom periods.
Laatste nieuws in bio
Japan Becomes First Country to Approve Reprogrammed Cell Treatments for Human Use
Tokyo, Saturday, 14 March 2026.
Japan’s health ministry has granted world-first regulatory approval for two medical treatments using reprogrammed human cells, marking a revolutionary milestone in regenerative medicine. The approved therapies include ReHeart for severe heart failure and Amusepri for Parkinson’s disease, both derived from induced pluripotent stem cells that can transform into any cell type. This breakthrough comes exactly twenty years after Japanese researcher Shinya Yamanaka pioneered the technology that won him a Nobel Prize, positioning Japan as the global leader in commercializing cellular reprogramming for medical applications.
